Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways

Induction of predominant tenogenic phenotype in human dermal fibroblasts via synergistic effect of TGF-β and elongated cell shape

(2016) Wenbo Wang (王文波) et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Mechanical coupling of cytoskeletal elasticity and force generation is crucial for understanding the migrating nature of keloid fibroblasts

(2015) Hans I-Chen Harn et al.   EXPERIMENTAL DERMATOLOGY

Keloid Pathogenesis: Potential Role of Cellular Fibronectin with the EDA Domain

(2015) Jonathan P. Andrews et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective

(2014) Lenie J. van den Broek et al.   EXPERIMENTAL DERMATOLOGY

Membrane palmitoylated protein 3 promotes hepatocellular carcinoma cell migration and invasion via up-regulating matrix metalloproteinase 1

(2013) Haijie Ma et al.   CANCER LETTERS

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation

(2013) Y-L Chen et al.   Cell Death & Disease

In vivo tendon engineering with skeletal muscle derived cells in a mouse model

(2012) Bo Chen et al.   BIOMATERIALS

The roles of receptor tyrosine kinases and their ligands in the wound repair process

(2012) Anna-Katharina Müller et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway

(2011) S. He et al.   BRITISH JOURNAL OF DERMATOLOGY

Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

(2011) Yue-Lei Chen et al.   HEPATOLOGY

Extracellular matrix molecules implicated in hypertrophic and keloid scarring

(2011) G.P. Sidgwick et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Unknown

(2011) Gerd Gauglitz et al.   MOLECULAR MEDICINE

The role of stem cell factor and c-KIT in keloid pathogenesis: do tyrosine kinase inhibitors have a potential therapeutic role?

(2010) A. Mukhopadhyay et al.   BRITISH JOURNAL OF DERMATOLOGY

A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population

(2010) Mitsuko Nakashima et al.   NATURE GENETICS

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion

(2010) Dimitra Bourboulia et al.   SEMINARS IN CANCER BIOLOGY

Keloid explant culture: a model for keloid fibroblasts isolation and cultivation based on the biological differences of its specific regions

(2010) Vanina Monique Tucci-Viegas et al.   International Wound Journal

Molecular dissection of abnormal wound healing processes resulting in keloid disease

(2009) Barbara Shih et al.   WOUND REPAIR AND REGENERATION

Genetic susceptibility to Keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans

(2008) Jason J. Brown et al.   EXPERIMENTAL DERMATOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Metalloproteinases and their inhibitors: Regulators of wound healing

(2007) S GILL et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Human Skin Keloid Fibroblasts Display Bioenergetics of Cancer Cells

(2007) Annette S. Vincent et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY